A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -87.73%. However, over the past six months, we’ve seen a stronger performance of -48.90%. The price of PLRX fallen by 1.89% over the last 30 days. And in the last five days, it has surged by 10.20%.
The stock price for Pliant Therapeutics Inc (PLRX) currently stands at $1.62. The stock experienced a substantial increase in the last session, hitting $4.0 after starting at $1.62. The stock’s lowest price was $1.7 before closing at $1.49.
Pliant Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $16.10 on 11/06/24 and the lowest value was $1.10 on 04/09/25.
52-week price history of PLRX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Pliant Therapeutics Inc’s current trading price is -89.94% away from its 52-week high, while its distance from the 52-week low is 47.26%. The stock’s price range during this time has been between $1.10 and $16.10. The trading volume for the Healthcare sector company’s shares reached about 0.73 million for the day, which was lower than the average daily volume of 1.27 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Pliant Therapeutics Inc (PLRX) has experienced a quarterly rise of 26.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 99.45M and boasts a workforce of 171 employees.
Pliant Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating Pliant Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 10 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4442, with a change in price of +0.2100. Similarly, Pliant Therapeutics Inc recorded 1,138,805 in trading volume during the last 100 days, posting a change of +14.89%.
PLRX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PLRX stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.27.
PLRX Stock Stochastic Average
Today’s raw stochastic average for Pliant Therapeutics Inc over the last 50 days is 74.24%.This indicates a increase from the raw stochastic average of the past 20 days, which was 56.96%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 31.65% and 20.26%, respectively.
